Presumed prevalence analysis on suspected and highly suspected breast cancer lesions in São Paulo using BIRADS® criteria

Authors

  • Vivian Milani Universidade Federal de São Paulo — Escola Paulista de Medicina
  • Suzan Menasce Goldman Universidade Federal de São Paulo — Escola Paulista de Medicina
  • Flora Finguerman Universidade Federal de São Paulo — Escola Paulista de Medicina
  • Marianne Pinotti Universidade Federal de São Paulo — Escola Paulista de Medicina
  • Celso Scazufka Ribeiro Universidade Federal de São Paulo — Escola Paulista de Medicina
  • Nitamar Abdalla Universidade Federal de São Paulo — Escola Paulista de Medicina
  • Jacob Szejnfeld Universidade Federal de São Paulo — Escola Paulista de Medicina

Keywords:

Mammography, Breast neoplasm, Determination, Epidemiology, Statistics

Abstract

CONTEXT AND OBJECTIVE: Breast cancer screening programs are critical for early detection of breast cancer. Early detection is essential for diagnosing, treating and possibly curing breast cancer. Since there are no data on the incidence of breast cancer, nationally or regionally in Brazil, our aim was to assess women by means of mammography, to determine the prevalence of this disease. DESIGN AND SETTING: The study protocol was designed in collaboration between the Department of Diagnostic Imaging (DDI), Institute of Diagnostic Imaging (IDI) and São Paulo Municipal Health Program. METHODS: A total of 139,945 Brazilian women were assessed by means of mammography between April 2002 and September 2004. Using the American College of Radiology (ACR) criteria (Breast Imaging Reporting and Data System, BIRADS®), the prevalence of suspected and highly suspected breast lesions were determined. RESULTS: The prevalence of suspected (BIRADS® 4) and highly suspected (BIRADS® 5) lesions increased with age, especially after the fourth decade. Accordingly, BIRADS® 4 and BIRADS® 5 lesions were more prevalent in the fourth, fi fth, sixth and seventh decades. CONCLUSION: The presumed prevalence of suspected and highly suspected breast cancer lesions in the population of São Paulo was 0.6% and it is similar to the prevalence of breast cancer observed in other populations.

Downloads

Download data is not yet available.

Author Biographies

Vivian Milani, Universidade Federal de São Paulo — Escola Paulista de Medicina

MD. Breast Radiology Postgraduate Fellow, Universidade Federal de São Paulo — Escola Paulista de Medicina (Unifesp-EPM), São Paulo, Brazil.

Suzan Menasce Goldman, Universidade Federal de São Paulo — Escola Paulista de Medicina

MD. Associate researcher, Department of Diagnostic Imaging, Universidade Federal de São Paulo — Escola Paulista de Medicina (Unifesp-EPM). Head of mammography section of the Perola Byington Hospital, São Paulo, Brazil.

Flora Finguerman, Universidade Federal de São Paulo — Escola Paulista de Medicina

MD. Breast Radiology Postgraduate Fellow, Universidade Federal de São Paulo — Escola Paulista de Medicina (Unifesp-EPM), São Paulo, Brazil.

Marianne Pinotti, Universidade Federal de São Paulo — Escola Paulista de Medicina

MD. Head of Breast Section of the Perola Byington Hospital, São Paulo, Brazil.

Celso Scazufka Ribeiro, Universidade Federal de São Paulo — Escola Paulista de Medicina

MD. Health Department, São Paulo, Brazil.

Nitamar Abdalla, Universidade Federal de São Paulo — Escola Paulista de Medicina

MD. Head of the Institute of Diagnostic Imaging (IDI), Universidade Federal de São Paulo — Escola Paulista de Medicina (Unifesp-EPM), São Paulo, Brazil.

Jacob Szejnfeld, Universidade Federal de São Paulo — Escola Paulista de Medicina

MD. Head of the Department of Diagnostic Imaging, Universidade Federal de São Paulo — Escola Paulista de Medicina (Unifesp-EPM), São Paulo, Brazil.

References

Tabar L, Fagerberg G, Chen HH, et al. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer. 1995;75(10):2507-17.

Ministério da Saúde. Instituto Nacional de Câncer. Coordenação de Programas de Controle do Câncer. O problema do câncer no Brasil. 4a ed. Rio de Janeiro: Pro-Onco; 1997.

Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer. 1977;39(6 Suppl):2772-82.

Kopans DB. The use of mammography for screening. JAMA. 1994;271(13):982-3.

Smith RA. IARC Handbooks of Cancer Prevention, Volume 7: Breast Cancer Screening. Breast Cancer Res. 2003;5(4):216-7. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=165025. Accessed in 2007 (May 24).

Ministério da Saúde. Instituto Nacional de Câncer. Documento de Consenso. Estimativa/2006. Incidência de Câncer no Brasil. Available from: http://www.inca.gov.br/estimativa/2006/. Accessed in 2007 (May 24).

American College of Radiology. Breast imaging reporting and data system. 3rd ed. Reston: American College of Radiology; 1998.

American College of Radiology. ACR Practice guideline for the performance of diagnostic mammography. Diagnostic mammog- raphy. 2002:405-9. Available from: http://www.acr.org/s_acr/bin.asp?CID=549&DID=12208&DOC=FILE.PDF. Accessed in 2007 (May 24).

Kemp C, Petti DA, Quadros LGO. Câncer de mama — prevenção primária. Projeto Diretrizes. São Paulo: Associação Médica Bra- sileira e Conselho Federal de Medicina. Sociedade Brasileira de Mastologia e Federação Brasileira das Sociedades de Ginecologia e Obstetrícia; 2002. Available from: http://www.projetodiretrizes.org.br/projeto_diretrizes/025.pdf. Accessed in 2007 (May 24).

Tabar L, Duffy SW, Chen HH. Re: Quantitative interpretation of age-specific mortality reductions from the Swedish Breast Cancer-Screening Trials. J Natl Cancer Inst. 1996;88(1):52-5.

Wright CJ, Mueller CB. Screening mammography and public health policy: the need for perspective. Lancet. 1995;346(8966):29-32.

Dershaw DD, Yahalom J, Petrek JA. Breast carcinoma in women previously treated for Hodgkin disease: mammographic evalua- tion. Radiology. 1992;184(2):421-3.

Smigel K. Breast cancer death rates decline for white women. J Natl Cancer Inst. 1995;87(3):173.

Olsen O, Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet. 2001;358(9290):1340-2.

Lee CH. Screening mammography: proven benefit, continued controversy. Radiol Clin North Am. 2002;40(3):395-407.

Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the International Workshop on Screening for Breast Cancer. J Nat Cancer Inst. 1993;85(20):1644-56.

Shapiro S. The status of breast cancer screening: a quarter of a century of research. World J Surg. 1989;13(1):9-18.

Baker LH. Breast Cancer Detection Demonstration Project: five- year summary report. CA Cancer J Clin. 1982;32(4):194-225.

Tabar L, Vitak B, Chen HH, Yen MF, Duffy SW, Smith RA. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer. 2001;91(9):1724-31.

Feig SA. Effect of service screening mammography on population mortality from breast carcinoma. Cancer. 2002;95(3):451-7.

Baines CJ, Miller AB, Kopans DB, et al. Canadian National Breast Screening Study: assessment of technical quality by external review. AJR Am J Roentgenol. 1990;155(4):743-7; discussion 748-9.

Frisell J, Glas U, Hellstrom L, Somell A. Randomized mam- mographic screening for breast cancer in Stockholm. Design, first round results and comparisons. Breast Cancer Res Treat. 1986;8(1):45-54.

Kopans DB, Feig SA. The Canadian National Breast Screening Study: a critical review. AJR Am J Roentgenol. 1993;161(4):755-60.

van der Mass PJ, de Koning HJ, van Ineveld BM, et al. The cost-effectiveness of breast cancer screening. Int J Cancer. 1989;43(6):1055-60.

Kopans DB, Monsees B, Feig SA. Screening for cancer: when is it valid? --Lessons from the mammography experience. Radiology. 2003;229(2):319-27.

Sickles EA, Kopans DB. Deficiencies in the analysis of breast cancer screening data. J Natl Cancer Inst. 1993;85(20):1621-4.

Berlin L. Breast cancer, mammography, and malpractice litigation: the controversies continue. AJR Am J Roentgenol. 2003;180(5):1229-37.

Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137(5 Part 1):347-60.

Alexander FE, Anderson TJ, Brown HK, et al. 14 years of fol- low-up from the Edinburghrandomised trial of breast-cancer screening. Lancet. 1999;353(9168):1903-8.

American Cancer Society. Breast cancer facts and figures 2001- 2002. Atlanta: American Cancer Society; 2002. Available from: http://www.cancer.org/downloads/STT/BrCaFF2001.pdf. Accessed in 2007 (May 25).

Bird RE, Wallace TW, Yankaskas BC. Analysis of cancers missed at screening mammography. Radiology. 1992;184(3):613-7.

Downloads

Published

2007-07-07

How to Cite

1.
Milani V, Goldman SM, Finguerman F, Pinotti M, Ribeiro CS, Abdalla N, Szejnfeld J. Presumed prevalence analysis on suspected and highly suspected breast cancer lesions in São Paulo using BIRADS® criteria. Sao Paulo Med J [Internet]. 2007 Jul. 7 [cited 2025 Mar. 17];125(4):210-4. Available from: https://periodicosapm.emnuvens.com.br/spmj/article/view/2138

Issue

Vol. 125 No. 4 (2007)

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.